|
PHF6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.878230E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.044600E-03 |
| Normal-vs-Stage2 |
1.237600E-01 |
| Normal-vs-Stage3 |
6.424800E-04 |
| Normal-vs-Stage4 |
3.803800E-04 |
| Stage1-vs-Stage2 |
6.126000E-01 |
| Stage1-vs-Stage3 |
1.696840E-01 |
| Stage1-vs-Stage4 |
9.186000E-02 |
| Stage2-vs-Stage3 |
1.741030E-01 |
| Stage2-vs-Stage4 |
9.565900E-02 |
| Stage3-vs-Stage4 |
5.419400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.555720E-03 |
| Normal-vs-AfricanAmerican |
1.901960E-01 |
| Normal-vs-Asian |
1.345510E-02 |
| Caucasian-vs-AfricanAmerican |
4.554200E-01 |
| Caucasian-vs-Asian |
9.165600E-01 |
| AfricanAmerican-vs-Asian |
5.349400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.235300E-04 |
| Normal-vs-Female |
5.637100E-03 |
| Male-vs-Female |
2.016000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.293900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.257000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.123470E-03 |
| Normal-vs-Age(81-100Yrs) |
4.641800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.495600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.886220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.667000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.544200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.048400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.565800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.361820E-01 |
| Classical-VS-Follicular |
6.192800E-01 |
| Classical-VS-Other |
3.965800E-01 |
| Classical-VS-Normal |
1.101520E-02 |
| Tall-VS-Follicular |
3.606800E-01 |
| Tall-VS-Other |
9.334000E-01 |
| Tall-VS-Normal |
3.423600E-03 |
| Follicular-VS-Other |
5.791400E-01 |
| Follicular-VS-Normal |
2.178200E-02 |
| Other-VS-Normal |
8.328400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.159600E-03 |
| Normal-vs-N1 |
7.027100E-04 |
| N0-vs-N1 |
3.049800E-01 |
|
|
